US FDA Expands Label For BMS’s Camzyos Days After Phase III Stumble

Bristol Myers Squibb office building in Brisbane, CA
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Scrip